Pfizer recently announced it would increase the U.S. list price of its patented Covid treatment nirmatrelvir-ritonavir (Paxlovid) to $1,390 for a five-day treatment course. Experts at Harvard University have estimated that the cost of producing a five-day course of nirmatrelvir-ritonavir is $13.

cool, love that. i think it’s awesome that you can just unilaterally mark up the cost of an essential medicine like this.

I personally liked the working of “spikes” into the headline.
I also personally don’t like the price jump.
I’d love to know what their R&D cost that went into it was though.